1. Medtech Insight
  2. >>Device Area

Oncimmune Reels In New Strategy Head And More Capital

 
• By Tina Tan

Oncimmune, the UK specialist in autoantibody-based tests for early cancer detection, has bullked up its human and financial resources with the appointment of a chief medical and strategy officer, and the closing of an investment tranche from its Chinese partner.

Oncimmune Ltd. has appointed Adam Hill to the dual role of chief medical officer and chief strategy officer, effective April 9.

Hill is a medical doctor and engineer. He was most recently CMO, and later chief strategy officer, of McLaren Applied Technologies, where he focused on applying the company’s deep technical expertise to improving health outcomes

More from In Vitro Diagnostics

More from Diagnostics